Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
Yuemei Hu(Jiangsu Provincial Center for Disease Control and Prevention), Ningshao Xia(Xiamen University), Huirong Pan, Feixue Wei(Shanxi Medical University), Changgui Li(National Institutes for Food and Drug Control), Zhijie Lin(Nankai University), Juan Li(Nanjing Agricultural University), Jun Zhang(Army Medical University), Kai Chu(Jiangsu Provincial Center for Disease Control and Prevention), Hui Zhao(National Institutes for Food and Drug Control), Meng Guo(Xiamen University), Shoujie Huang(Xiamen University), Jing Zhang(Children's Hospital of Fudan University), Xiànghóng Wú(Shandong University), Wengang He(Xiamen University), Ting Wu(Xiamen University), Xingmei Yao(Shanghai University of Traditional Chinese Medicine), Yue Huang(Zhengzhou University)
Cited by 52
Related Papers
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|977
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655